Dicerna, Novo Nordisk sign RNAi deal for liver-related cardio-metabolic diseases
US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m to discover and develop drugs for liver-related cardio-metabolic diseases.
In...
Elsevier and FDA to work on AI algorithm for drug-induced liver injury
Elsevier is working with the National Center for Toxicological Research (NCTR) at the FDA on a predictive drug-induced liver injury (DILI) algorithm. The company...
Aquestive Therapeutics Receives FDA Approval for Exservan Oral Film
Aquestive Therapeutics, a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, announced that Exservan Oral Film received early-action...
Med-Tech Innovation Expo and Medilink UK renew partnership
Both organisations have collaborated successfully on the event since 2016, when Rapid took on the annual event. The future cooperation agreement covers initiatives including...
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
The global pharmaceutical company and service partner Inceptua Group and Bendalis GmbH – German manufacturer of generic oncology drugs and special therapeutic agents, announce...
Oakrum Pharma and SunGen Pharma Announce U.S. Launch of Generic Version of Medrol
Oakrum Pharma, LLC ("Oakrum"), in collaboration with SunGen Pharma, LLC ("SunGen"), announced the U.S. launch and commercial shipment of a generic version of Medrol®...
Fig extract for healthy blood sugar levels
A recently published human study from the University of Sydney, Australia, evaluated the efficacy of ABAlife™ on glucose metabolism blood parameters. The abscisic acid...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...